Generic Wegovy in Canada moved from wish to reality on June 29, 2026, when Health Canada authorized Sevmia, the first generic semaglutide approved for weight loss in this country. [1] Sevmia is not in pharmacies yet, and no price has been published. The approval still matters a great deal: brand Wegovy runs roughly $400 to $570 a month here, and generic competition is the one force that reliably pulls that number down. [3]
Our top pick: MyRocky is our highest-rated GLP-1 provider in Canada. They prescribe and fill brand Wegovy online, plus generic semaglutide from $149 a month, with a one-time $99 consult that includes lab work and service in all 10 provinces. Check current MyRocky pricing.
This page tracks what is confirmed about Sevmia, what is still unknown, and what you can do about your semaglutide costs today. For brand pricing, start with our Wegovy cost guide. For the cheapest semaglutide you can get right now, read our generic semaglutide guide and our MyRocky review.
Everything below reflects what was public as of early July 2026. We will update this page as Apotex confirms launch details for generic Wegovy.
What Is Sevmia?
Sevmia is the first generic Wegovy: a copy of Novo Nordisk's semaglutide 2.4 mg weekly injection for chronic weight management. Health Canada authorized it on June 29, 2026. It is the third generic semaglutide approved in Canada overall, and the first cleared for the weight-loss indication. [1] The two earlier generics copy Ozempic, the type 2 diabetes label. Sevmia copies the label most Canadians asking about weight loss actually want.
Apotex makes Sevmia. The company is Canadian-based and developed the product with Orbicular Pharmaceutical Technologies, announcing the approval in a press release on June 30. [2] I like that detail. A domestic manufacturer with existing relationships across Canadian wholesalers and pharmacy chains has a shorter road from approval to shelf than an overseas supplier shipping product in.
Who Sevmia Is Approved For
Apotex describes the indication as chronic weight management in adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition. The approval also covers reduction of non-fatal heart attack risk in adults with established cardiovascular disease and a BMI of 27 or higher. [2]
One wrinkle: Health Canada materials reference patients 12 and over, which mirrors Wegovy's adolescent indication. [1] The product monograph governs the exact criteria, and Apotex materials emphasize adults. Until the monograph circulates widely, treat the adult criteria as the safe assumption and let your prescriber confirm the rest.
The Pen Looks More Like Ozempic Than Wegovy
Press coverage describes Sevmia as a multi-use pre-filled pen that delivers 1 mg doses, with 4 mg of semaglutide per pen. [3][4] That is an Ozempic-style multi-dose pen rather than Wegovy's fixed-dose, single-use pens. The full strength lineup has not been confirmed, so check the product monograph as launch details firm up. If you currently use Wegovy's one-pen-per-week format, expect your pharmacist to walk you through a slightly different routine.
What We Know vs What We Do Not Know Yet
Honest reporting beats confident guessing on a page like this. Here is where generic Wegovy in Canada stands as of early July 2026.
Confirmed:
- Approved: Health Canada authorized Sevmia on June 29, 2026, the first generic semaglutide for weight loss in Canada. [1]
- Manufacturer: Apotex, Canadian-based, with development partner Orbicular Pharmaceutical Technologies. [2]
- Indication: Chronic weight management at BMI 30 or higher, or 27 or higher with a weight-related condition, plus heart attack risk reduction in adults with established cardiovascular disease. [2]
- Pen format (reported): A multi-use pen delivering 1 mg doses, 4 mg per pen, per press coverage. [3]
- More competition coming: Six more generic semaglutide submissions were under Health Canada review as of June 29. [1]
Not known yet:
- Launch date: No Canadian pharmacy lists Sevmia as of early July 2026.
- Price: Apotex has not published one, and no pharmacy has quoted one.
- Strength lineup: The reported 1 mg per dose format still needs product monograph confirmation.
- Coverage: No insurer or public formulary has listed Sevmia.
- Supply volume: Nobody knows how much product hits shelves in the first months.
Any article quoting a firm Sevmia price or a firm launch date ahead of Apotex is running past the facts.
When Will Sevmia Be Available in Canada?
The honest answer: likely within weeks to a few months, and nobody outside Apotex knows the date generic Wegovy hits shelves. Pharmacy stocking typically follows a Health Canada approval by weeks, once wholesalers pick up the product and the chains list it.
Generic Ozempic gives us the best precedent. Health Canada approved the first two Ozempic-label generics in late April and on May 1, 2026, and pharmacies were dispensing them within weeks. [7][8] Apotex shipped one of those generics, so the company has already run this exact play once in 2026. If Sevmia follows the same track, stocking in late July or August 2026 looks plausible. Treat that as a pattern-based estimate, not a promise.
| Date | What happened |
|---|---|
| June 29, 2026 | Health Canada authorizes Sevmia, the first generic Wegovy [1] |
| June 30, 2026 | Apotex announces the approval with partner Orbicular [2] |
| Early July 2026 | No pharmacy listings and no published price, which is where things stand now |
| The weeks ahead | Expected wholesaler and pharmacy stocking, following the generic Ozempic pattern [7][8] |
| Later in 2026 | Six more generic semaglutide submissions under review could add competitors [1] |
Want to be first in line? Ask your pharmacy to note your file and call you when Sevmia arrives. Pharmacies order against demand, and a list of waiting patients moves a product up the order sheet.
How Much Will Generic Wegovy Cost? Sevmia Cost Expectations
There is no confirmed Sevmia cost. What exists are two published pricing rules and one live precedent, and together they sketch a believable range.
Health Canada's June 29 release notes that generic drugs typically cost 45 to 90 percent less than the brand, and that once two generics compete in a market, prices must sit at least about 50 percent below the brand price. [1] Brand Wegovy retails for roughly $400 to $570 a month in Canada. [3] Apply the 50 percent floor and generic Wegovy lands under roughly $200 to $285 a month once competition kicks in. The wider 45 to 90 percent pattern stretches the possible landing zone from about $60 to $310 a month, depending on where the launch price settles.
Generic Ozempic is the precedent that makes me optimistic. It launched in May 2026 and now sells for roughly $88 to $120 a month at Canadian pharmacies, with Costco at $88 to $99. [7] That undercuts brand Ozempic by well over half. If Sevmia and the six submissions behind it follow that curve, weight-loss semaglutide could become genuinely affordable for cash-pay Canadians within a year.
| Product | Monthly cost (CAD) | Status (July 2026) |
|---|---|---|
| Brand Wegovy | $400 to $570 | In pharmacies now [3] |
| Sevmia (generic Wegovy) | No published price; pricing rules point below $200 to $285 | Approved June 29, 2026; not yet stocked [1] |
| Generic semaglutide (Ozempic label, off-label for weight loss) | $88 to $120 at pharmacies; $149 at MyRocky all-in | In pharmacies since May 2026 [7] |
Treat every Sevmia number floating around as an expectation, not a quote. The day a real price publishes, we will update this page and our Wegovy cost breakdown.
What to Do While You Wait
Waiting for Sevmia makes sense if your current setup works. If the monthly bill is the problem, four routes exist today.
1. Stay on Brand Wegovy
If Wegovy is working and you can carry the $400 to $570 a month, there is no medical reason to switch ahead of the generic. [3] Brand pricing may also move on its own: manufacturers tend to respond once generics land, the way Novo Nordisk's savings card cut brand Ozempic prices for uninsured Canadians outside Quebec starting in late May 2026. [6] Watch for a similar response on the Wegovy side once Sevmia ships.
2. Check the Savings Routes That Exist Now
Before paying full sticker, read our Wegovy savings card guide for what actually reduces the brand price in Canada, and confirm anything your pharmacy offers on top. Manufacturer programs shift quickly when generic competition arrives, so a route that did not exist in the spring may exist now. No provincial public plan covers weight-loss GLP-1s, so cash-pay strategy matters more here than it does for diabetes medications.
3. Ask About Generic Semaglutide, Prescribed Off-Label
Generic semaglutide for weight loss in Canada today means the Ozempic-label generic, prescribed off-label where your clinician judges it appropriate. The molecule is the same: semaglutide. The label differs, and Wegovy's weight-loss dosing runs to 2.4 mg weekly, so this is a conversation for your prescriber rather than a straight swap.
The price case is strong. Pharmacy shelves have carried generic Ozempic since May 2026 at roughly $88 to $120 a month, with Costco at $88 to $99. [7] Our generic Ozempic guide covers pharmacy-by-pharmacy pricing and how the substitution works.
4. Go Through Telehealth
MyRocky sells generic semaglutide at $149 a month all-in and also prescribes brand Wegovy, with a one-time $99 consult that includes lab work and service in all 10 provinces. For cash-pay patients who want weight-loss treatment running before generic Wegovy stocks, this is the closest available option today. Read our full MyRocky review or check current MyRocky pricing directly.
Online Providers Cost Comparison
No telehealth platform lists Sevmia yet, which tracks with the product not being in distribution. Here is where pricing stands for what you can get today.
| Provider | Brand Wegovy | Generic Semaglutide | Consult Fee | Learn More |
|---|---|---|---|---|
| MyRocky ⭐ Top Pick | Prescribed and filled online | $149/month all-in | One-time $99, includes lab work | Visit MyRocky |
| Felix Health | Confirm availability | $149/month all-in [9] | Included in pricing | Visit Felix |
| Maple | Prescription only, fill at your pharmacy | Prescription only | Per-visit fee | maple.ca |
Once Sevmia reaches wholesalers, expect these menus to change fast. Telehealth platforms added generic Ozempic within weeks of its May 2026 launch, and the same race will play out for generic Wegovy.
Will Insurance Cover Generic Wegovy?
No provincial public plan covers weight-loss GLP-1s, and Sevmia's approval does not change that on its own. Brand or generic, the weight-loss indication sits outside every provincial formulary today.
Private plans write their own rules. Some cover weight-loss GLP-1s with prior authorization, and a cheaper generic gives those plans a reason to say yes more often. Ask your insurer two questions: does my plan cover semaglutide for weight management, and will it list the generic once it is available. Get the answer in writing before you count on it.
FAQ
What is Sevmia?
Sevmia is the first generic version of Wegovy approved in Canada. Health Canada authorized it on June 29, 2026 for chronic weight management, making it the first generic semaglutide cleared for weight loss and the third generic semaglutide approval overall. [1] Apotex, a Canadian-based manufacturer, developed it with Orbicular Pharmaceutical Technologies. [2]
When will Sevmia be available in Canada?
No launch date has been announced. As of early July 2026, no Canadian pharmacy lists Sevmia and no price is published. Stocking typically follows a Health Canada approval by weeks: the Ozempic-label generics approved in late April and on May 1, 2026 were on shelves within May. [7][8] Ask your pharmacy to flag your file so they call you when it lands.
How much will generic Wegovy cost in Canada?
No price is published yet. Health Canada notes generics typically run 45 to 90 percent below brand, and prices must sit at least about 50 percent below brand once two generics compete. [1] With brand Wegovy at roughly $400 to $570 a month, that points below $200 to $285. [3] Generic Ozempic already sells for $88 to $120 a month, so a similar path for generic Wegovy is realistic over time. [7]
Is Sevmia the same as Wegovy?
Same active ingredient: semaglutide, approved as a generic for chronic weight management. Health Canada requires a generic to prove equivalence to the brand before authorizing it. The reported pen format differs, though: press coverage describes a multi-use pen delivering 1 mg doses rather than Wegovy's single-use fixed-dose pens, so confirm the details in the product monograph once it circulates. [3]
Can I get generic semaglutide for weight loss in Canada right now?
Yes, through an off-label route. The Ozempic-label generic has been in Canadian pharmacies since May 2026 at roughly $88 to $120 a month, and clinicians can prescribe it off-label for weight loss where appropriate. [7] MyRocky offers it at $149 a month all-in online and also prescribes brand Wegovy.
Who makes Sevmia?
Apotex, a Canadian-based generic manufacturer, developed Sevmia with Orbicular Pharmaceutical Technologies and announced the Health Canada approval on June 30, 2026. [2] Apotex also shipped one of the Ozempic-label generics that launched in May 2026, so it has recent experience getting semaglutide onto Canadian shelves. [8]
This article is informational and is not a substitute for medical advice from your prescribing clinician. Always confirm pricing and coverage directly with the pharmacy and your insurer before filling.
Sources
- Canada approves first generic semaglutide for weight loss: Health Canada news release announcing Sevmia's authorization (June 29, 2026).
- Apotex First to Receive Health Canada Approval for Sevmia, a Generic Semaglutide for Chronic Weight Management: Apotex press release via PR Newswire (June 30, 2026).
- Apotex receives approval for generic version of weight-loss drug Wegovy: CBC News coverage of the Sevmia approval and pen format (June 2026).
- Canada approves generic semaglutide injection for weight loss: Global News report on the approval (June 2026).
- Canada approves first generic Wegovy (semaglutide) for weight loss: The Globe and Mail report on the approval and brand pricing context (June 2026).
- Novo Nordisk slashes Ozempic price in Canada as generics arrive: Global News report on Novo Nordisk's savings card for uninsured Canadians outside Quebec (May 2026).
- Canada becomes the first G7 country to approve a generic version of semaglutide: Health Canada news release on the first Ozempic-label generic (April 28, 2026).
- Canada approves second generic semaglutide, the first G7 country to do so: Health Canada news release on Apotex's Ozempic-label generic (May 1, 2026).
- Generic semaglutide pricing: Felix Health public pricing page for generic semaglutide (2026).